DZ3046A1 - Hydroxamides d'acides 3-(arylsulfonylamino)-tétrahydropyranne-3-carboxyliques, procédé pour leur préparation et compositions pharmaceutiques les contenant. - Google Patents

Hydroxamides d'acides 3-(arylsulfonylamino)-tétrahydropyranne-3-carboxyliques, procédé pour leur préparation et compositions pharmaceutiques les contenant.

Info

Publication number: DZ3046A1
Authority: DZ; Algeria
Prior art keywords: hydroxamides; arylsulfonylamino; tetrahydropyran; preparation; pharmaceutical compositions
Prior art date: 1999-05-28

Application number

DZ000090A

Other languages

English (en)

French (fr)

Inventor

Lawrence Alan Reiter

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-05-28

Filing date

2000-05-24

Publication date

2004-03-27

2000-05-24 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2004-03-27 Application granted granted Critical

2004-03-27 Publication of DZ3046A1 publication Critical patent/DZ3046A1/xx

Links

125000004657 aryl sulfonyl amino group Chemical group 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 abstract 2
206010028980 Neoplasm Diseases 0.000 abstract 2
201000011510 cancer Diseases 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 2
STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 abstract 1
WEAHRLBPCANXCN-UHFFFAOYSA-N Daunomycin Natural products CCC1(O)CC(OC2CC(N)C(O)C(C)O2)c3cc4C(=O)c5c(OC)cccc5C(=O)c4c(O)c3C1 WEAHRLBPCANXCN-UHFFFAOYSA-N 0.000 abstract 1
ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 abstract 1
229930012538 Paclitaxel Natural products 0.000 abstract 1
229940009456 adriamycin Drugs 0.000 abstract 1
229930013930 alkaloid Natural products 0.000 abstract 1
229940035676 analgesics Drugs 0.000 abstract 1
239000000730 antalgic agent Substances 0.000 abstract 1
206010003246 arthritis Diseases 0.000 abstract 1
238000002648 combination therapy Methods 0.000 abstract 1
229940111134 coxibs Drugs 0.000 abstract 1
239000003255 cyclooxygenase 2 inhibitor Substances 0.000 abstract 1
231100000433 cytotoxic Toxicity 0.000 abstract 1
230000001472 cytotoxic effect Effects 0.000 abstract 1
STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 abstract 1
229960005420 etoposide Drugs 0.000 abstract 1
239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 1
201000008482 osteoarthritis Diseases 0.000 abstract 1
229960001592 paclitaxel Drugs 0.000 abstract 1
229910052697 platinum Inorganic materials 0.000 abstract 1
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 abstract 1
206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 abstract 1
229940063683 taxotere Drugs 0.000 abstract 1
OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 abstract 1
229960004528 vincristine Drugs 0.000 abstract 1
-1 vincristine Natural products 0.000 abstract 1
OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/14—Nitrogen atoms not forming part of a nitro radical

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Diabetes (AREA)
Communicable Diseases (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Oncology (AREA)
Psychiatry (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Virology (AREA)
Hematology (AREA)
Psychology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Transplantation (AREA)
Obesity (AREA)
Ophthalmology & Optometry (AREA)
Hospice & Palliative Care (AREA)
Endocrinology (AREA)

DZ000090A 1999-05-28 2000-05-24 Hydroxamides d'acides 3-(arylsulfonylamino)-tétrahydropyranne-3-carboxyliques, procédé pour leur préparation et compositions pharmaceutiques les contenant. DZ3046A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US13653099P	1999-05-28	1999-05-28

Publications (1)

Publication Number	Publication Date
DZ3046A1 true DZ3046A1 (fr)	2004-03-27

Family

ID=22473239

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ000090A DZ3046A1 (fr)	1999-05-28	2000-05-24	Hydroxamides d'acides 3-(arylsulfonylamino)-tétrahydropyranne-3-carboxyliques, procédé pour leur préparation et compositions pharmaceutiques les contenant.

Country Status (22)

Country	Link
US (1)	US6197810B1 (xx)
EP (1)	EP1181286B1 (xx)
JP (1)	JP3784645B2 (xx)
AT (1)	ATE254119T1 (xx)
AU (1)	AU4424000A (xx)
BR (1)	BR0011539A (xx)
CA (1)	CA2375524C (xx)
DE (1)	DE60006523T2 (xx)
DK (1)	DK1181286T3 (xx)
DZ (1)	DZ3046A1 (xx)
ES (1)	ES2208315T3 (xx)
GT (1)	GT200000079A (xx)
HN (1)	HN2000000074A (xx)
MA (1)	MA26738A1 (xx)
MX (1)	MXPA01012265A (xx)
PA (1)	PA8495901A1 (xx)
PE (1)	PE20010170A1 (xx)
PT (1)	PT1181286E (xx)
SV (1)	SV2001000086A (xx)
TN (1)	TNSN00111A1 (xx)
UY (1)	UY26167A1 (xx)
WO (1)	WO2000073295A1 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040122011A1 (en) *	1998-12-23	2004-06-24	Pharmacia Corporation	Method of using a COX-2 inhibitor and a TACE inhibitors as a combination therapy
EP1265865A2 (en)	2000-03-21	2002-12-18	The Procter & Gamble Company	Difluorobutyric acid derivatives and their use as metalloprotease inhibitors
HUP0300235A2 (hu)	2000-03-21	2003-08-28	The Procter & Gamble Co.	Heterociklikus oldalláncot tartalmazó, N-szubsztituált metalloproteáz inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
WO2001070690A1 (en) *	2000-03-21	2001-09-27	The Procter & Gamble Company	Heterocyclic side chain containing metalloprotease inhibitors
US7019376B2 (en) *	2000-08-11	2006-03-28	Reflectivity, Inc	Micromirror array device with a small pitch size
US20030045449A1 (en) *	2001-08-15	2003-03-06	Pfizer, Inc.	Pharmaceutical combinations for the treatment of neurodegenerative diseases
GB0319069D0 (en) *	2003-08-14	2003-09-17	Glaxo Group Ltd	Therapeutically useful compounds
US20050058611A1 (en) *	2003-08-22	2005-03-17	L'oreal	Preventing and/or combating collagen fiber degradation induced under conditions of natural exposure to sunlight
ES2536191T3 (es)	2009-01-12	2015-05-21	Pfizer Limited	Derivados de sulfonamida
WO2012004706A2 (en)	2010-07-09	2012-01-12	Pfizer Limited	Chemical compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5455258A (en) *	1993-01-06	1995-10-03	Ciba-Geigy Corporation	Arylsulfonamido-substituted hydroxamic acids
CN1113862C (zh)	1997-02-03	2003-07-09	辉瑞产品公司	芳基磺酰氨基异羟肟酸衍生物
PA8469501A1 (es) *	1998-04-10	2000-09-29	Pfizer Prod Inc	Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxilico

2000
- 2000-05-15 MX MXPA01012265A patent/MXPA01012265A/es active IP Right Grant
- 2000-05-15 WO PCT/IB2000/000647 patent/WO2000073295A1/en active IP Right Grant
- 2000-05-15 BR BR0011539-8A patent/BR0011539A/pt not_active IP Right Cessation
- 2000-05-15 JP JP2000621361A patent/JP3784645B2/ja not_active Expired - Fee Related
- 2000-05-15 AU AU44240/00A patent/AU4424000A/en not_active Abandoned
- 2000-05-15 CA CA002375524A patent/CA2375524C/en not_active Expired - Fee Related
- 2000-05-15 ES ES00925520T patent/ES2208315T3/es not_active Expired - Lifetime
- 2000-05-15 HN HN2000000074A patent/HN2000000074A/es unknown
- 2000-05-15 AT AT00925520T patent/ATE254119T1/de not_active IP Right Cessation
- 2000-05-15 PT PT00925520T patent/PT1181286E/pt unknown
- 2000-05-15 EP EP00925520A patent/EP1181286B1/en not_active Expired - Lifetime
- 2000-05-15 DK DK00925520T patent/DK1181286T3/da active
- 2000-05-15 DE DE60006523T patent/DE60006523T2/de not_active Expired - Fee Related
- 2000-05-19 PA PA20008495901A patent/PA8495901A1/es unknown
- 2000-05-24 DZ DZ000090A patent/DZ3046A1/xx active
- 2000-05-24 MA MA25988A patent/MA26738A1/fr unknown
- 2000-05-24 TN TNTNSN00111A patent/TNSN00111A1/fr unknown
- 2000-05-25 GT GT200000079A patent/GT200000079A/es unknown
- 2000-05-26 US US09/579,059 patent/US6197810B1/en not_active Expired - Fee Related
- 2000-05-26 PE PE2000000507A patent/PE20010170A1/es not_active Application Discontinuation
- 2000-05-26 SV SV2000000086A patent/SV2001000086A/es not_active Application Discontinuation
- 2000-05-26 UY UY26167A patent/UY26167A1/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
ES2208315T3 (es)	2004-06-16
HN2000000074A (es)	2001-02-02
MA26738A1 (fr)	2004-12-20
US6197810B1 (en)	2001-03-06
GT200000079A (es)	2001-11-16
UY26167A1 (es)	2000-12-29
PT1181286E (pt)	2004-02-27
SV2001000086A (es)	2001-11-08
PE20010170A1 (es)	2001-02-27
EP1181286A1 (en)	2002-02-27
CA2375524C (en)	2006-11-28
MXPA01012265A (es)	2002-07-30
ATE254119T1 (de)	2003-11-15
DE60006523D1 (de)	2003-12-18
TNSN00111A1 (fr)	2002-05-30
JP2003500485A (ja)	2003-01-07
BR0011539A (pt)	2002-02-26
JP3784645B2 (ja)	2006-06-14
EP1181286B1 (en)	2003-11-12
WO2000073295A1 (en)	2000-12-07
CA2375524A1 (en)	2000-12-07
DE60006523T2 (de)	2004-08-12
PA8495901A1 (es)	2002-08-26
AU4424000A (en)	2000-12-18
DK1181286T3 (da)	2004-02-16

Publication	Publication Date	Title
TNSN99157A1 (fr)	2005-11-10	Derives d'hydroxamides heterocycliques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
YU5201A (sh)	2003-07-07	Derivati hidroksipipekolathidroksamske kiseline kao inhibitori mmp
EA199900641A1 (ru)	2000-04-24	Производные арилсульфонилгидроксамовой кислоты
DZ3020A1 (fr)	2004-03-20	Acides oxamiques nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MY121754A (en)	2006-02-28	Arylsulfonylamino hydroxamic acid derivatives
AP9801174A0 (en)	1998-01-31	Cyclic sulfone derivatives.
DZ2773A1 (fr)	2003-12-01	Pyrazolopyrimidinones nouvelles procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3042A1 (fr)	2004-03-27	Dérivés d'isothiazole nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
GEP20053595B (en)	2005-08-10	Cyclopentanoindoles, Compositions Containing Such Compounds and Methods of Treatment
DZ2963A1 (fr)	2004-03-15	Dérivés de bicycliques substituées nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
EA199900036A1 (ru)	1999-06-24	Ингибиторы металлопротеаз матрикса на основе фосфинатов, фармацевтическая композиция, способ лечения
DZ3045A1 (fr)	2004-03-27	Dérivés de i 3-méthyl-érythromycine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3046A1 (fr)	2004-03-27	Hydroxamides d'acides 3-(arylsulfonylamino)-tétrahydropyranne-3-carboxyliques, procédé pour leur préparation et compositions pharmaceutiques les contenant.
BG106694A (en)	2003-03-31	Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
DZ3048A1 (fr)	2004-03-27	Précurseurs médicamenteux mutuels d'amlopidine et d'atorvastine, procédé pour leur préparation et compositions pharmaceutiques les contenant.
TNSN00114A1 (fr)	2002-05-30	Hydroxamides d'acide 3-(arylsulfonylamino)-tetrahydrofuranne-3- carboxyliques, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ3044A1 (fr)	2004-03-27	Dérivés de 1-trifluorométhyl-4-hydroxy-7-pipéridinyl-aminométhyl-chromane, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3047A1 (fr)	2004-03-27	Sel mutuel d'amlopidine et d'atorvastatine, procédé pour sa préparation et compositions pharmaceutiques les contenant.
DZ3040A1 (fr)	2004-03-27	Benzolactames et thioamides cycliques substitués nouveaux, procédé pour préparation et compositions pharmaceutiques les contenant.
EP2054398A4 (en)	2010-10-13	NEW HETEROCYCLIC COMPOUNDS CONTAINING NITROGENATOME AND THEIR PHARMACEUTICALALLY SALTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CANCER CONTAINING THEREOF
FR2645747B1 (fr)	1991-07-12	Nouvelles compositions pharmaceutiques, leur procede d'obtention et leur emploi en therapeutique tumorale